Clinical Trials Logo

Filter by:
NCT ID: NCT01696396 Completed - Crohn's Disease Clinical Trials

Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

Start date: December 4, 2012
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of abrilumab as measured by the proportion of participants achieving Crohn's Disease Activity Index (CDAI) remission (CDAI < 150) after treatment for 8 weeks.

NCT ID: NCT01695603 Completed - Clinical trials for Brain Injured Patients

Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients

Start date: March 2012
Phase: N/A
Study type: Interventional

Comparison of the ability of a new automated ventilatory mode named Intellibrain to maintain capnia and oxgen partial pressure within predefined ranges in comparison to the control of capnia and oxgen partial pressure obtained by using standard controlled ventilation modes in brain injured patients. Comparison of the numbers of alarms and required settings modifications observed with each ventilatory mode.

NCT ID: NCT01694654 Active, not recruiting - Clinical trials for Solitary Fibrous Tumors of the Pleura

Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.

Start date: September 2012
Phase: Phase 4
Study type: Observational

1. To determine the incidence, prevalence and long-term outcome of patients with SFTP in the German spoken part of Switzerland. 2. To define the role of immunohistochemical and molecular techniques, such as immunostaining, FISH and mutational analysis regarding their ability to predict malignant behavior in terms of prediction of overall survival and disease-free survival.

NCT ID: NCT01694485 Completed - Ulcerative Colitis Clinical Trials

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Start date: November 16, 2012
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effect of abrilumab on induction of remission in adults with moderate to severe ulcerative colitis after 8 weeks of treatment as assessed by a total Mayo Score ≤ 2 points, with no individual subscore > 1 point.

NCT ID: NCT01693926 Completed - Obesity Clinical Trials

Effect of Physical Activity an Stress in Children

Start date: September 2012
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the impact of physical activity in obese and nonobese prepubertal children on: 1. biological stress responses during a psychosocial stress test 2. snacking and feeling of hunger in response to the same psychosocial stress test 3. the moderating factor of attachment on the biological stress responses and on snacking Children will be investigated on one study day during 3.5 hours.

NCT ID: NCT01693367 Terminated - Clinical trials for Distal Femur Fractures

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

Start date: September 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the performance of Dynamic Locking Screws (DLS) used to stabilize the shaft component of distal femur fractures in comparison to standard locking screws (SLS). The hypothesis is that DLS will lead to better functional outcomes (WOMAC score) due to increased and more symmetrical callus formation and fewer non-unions.

NCT ID: NCT01693146 Recruiting - COPD Clinical Trials

STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia

STIT-2
Start date: December 2011
Phase: Phase 1
Study type: Interventional

Evaluation of Safety and Efficacy of Short time TNI Treatment in Patients with COPD and hypercapnia. Acute testing of oxygen demand using TNI vs. standard oxygen application in stable COPD patients with hypercapnia.

NCT ID: NCT01693068 Completed - Clinical trials for N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Start date: December 5, 2012
Phase: Phase 2
Study type: Interventional

This is a Phase 2, multicenter, randomized, controlled, open-label trial of pimasertib versus dacarbazine aimed to confirm the activity of pimasertib in previously untreated subjects with N-Ras mutated locally advanced or metastatic malignant cutaneous melanoma by comparing the progression-free survival (PFS) of subjects treated with either pimasertib or dacarbazine and by getting a better understanding of the efficacy, safety, pharmacogenomics (PGx) and their relationship with pimasertib exposure.

NCT ID: NCT01692704 Completed - Clinical trials for Cholangiocellular Carcinoma

Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy

Start date: April 2012
Phase: Phase 1/Phase 2
Study type: Interventional

An open label, prospective, non-randomized single arm study. Combination of two treatment modalities - HAI with FUDR and systemic chemotherapy with cisplatin and gemcitabine. Definition of the maximum tolerated dose (MTD) of intravenous gemcitabine in combination with intravenous cisplatin and intra-arterial FUDR. Definition of safety and toxicity of this combined regional and systemic treatment approach. Definition of the response rate after 3 months of hepatic intra-arterial chemotherapy with continuous infusion FUDR with or without ligation of the right or left portal vein, in combination with 3 months of systemic cisplatin and gemcitabine in patients with unresectable intrahepatic or hilar CCC. A total of 9-18 patients are required. 3-6 patients per dose level. A maximum of three dose levels (1 - 3) has been defined. Statistical Methodology: Traditional 3+3 dosing algorithm to find MTD. - Trial with medicinal product

NCT ID: NCT01692535 Completed - Clinical trials for Intubation; Difficult

Evaluation of Video Laryngoscopes in Difficult Airway

SWIVIT I
Start date: January 2013
Phase: N/A
Study type: Interventional

In this multicenter study the investigators are going to evaluate the use of six different videolaryngoscopes in patients undergoing elective surgery requiring general anesthesia with intubation. The investigators are hypothesizing that these six videolaryngoscopes will succeed for intubation at first attempt in at least 90% of all cases using a difficult airway simulation with extrication collars. As gold standard, a standard Macintosh blade is being used. The study consists of 6 arms. Each arm includes 120 patients, sums up to a total of 720 patients.